Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Riedemann

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
JMIR XR and Spatial Computing|December 4, 2025
Discovering and Creating the Leading Edge of Extended Reality and Spatial Computing: A Message From the Editor-in-ChiefLars Riedemann
NPJ Digital Medicine|November 28, 2024
The path forward for large language models in medicine is openLars Riedemann, Maxime Labonne, Stephen Gilbert
Cancer Journal (Sudbury, Mass.)|July 30, 2015
Targeting the Tumor Microenvironment to Enhance Pediatric Brain Cancer TreatmentAna Batista, Lars Riedemann, Trupti Vardam, et al.
Nature Medicine|February 5, 2025
Safe AI-enabled digital health technologies need built-in open feedbackRebecca Mathias, Baptiste Vasey, Anastasia Chalkidou, et al.
Molecular Cancer Therapeutics|August 1, 2012
REST is a novel prognostic factor and therapeutic target for medulloblastomaPete Taylor, Jason Fangusaro, Veena Rajaram, et al.
Journal of Neuro-Oncology|March 6, 2021
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?Sina Burth, Mona Ohmann, Dorothea Kronsteiner, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2018
Nonmeasurable Speckled Contrast-Enhancing Lesions Appearing During Course of Disease Are Associated With IDH Mutation in High-Grade Astrocytoma PatientsAnne Berberich, Thomas Hielscher, Philipp Kickingereder, et al.
Developmental Cell|September 5, 2017
YAP/TAZ Orchestrate VEGF Signaling during Developmental AngiogenesisXiaohong Wang, Aida Freire Valls, Géza Schermann, et al.
Neuro-Oncology Advances|July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastasesAnna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
The Lancet. Digital Health|February 26, 2022
Advancing digital health applications: priorities for innovation in real-world evidence generationAriel D Stern, Jan Brönneke, Jörg F Debatin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
JMIR XR and Spatial Computing|December 4, 2025
Discovering and Creating the Leading Edge of Extended Reality and Spatial Computing: A Message From the Editor-in-ChiefLars Riedemann
NPJ Digital Medicine|November 28, 2024
The path forward for large language models in medicine is openLars Riedemann, Maxime Labonne, Stephen Gilbert
Cancer Journal (Sudbury, Mass.)|July 30, 2015
Targeting the Tumor Microenvironment to Enhance Pediatric Brain Cancer TreatmentAna Batista, Lars Riedemann, Trupti Vardam, et al.
Nature Medicine|February 5, 2025
Safe AI-enabled digital health technologies need built-in open feedbackRebecca Mathias, Baptiste Vasey, Anastasia Chalkidou, et al.
Molecular Cancer Therapeutics|August 1, 2012
REST is a novel prognostic factor and therapeutic target for medulloblastomaPete Taylor, Jason Fangusaro, Veena Rajaram, et al.
Journal of Neuro-Oncology|March 6, 2021
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?Sina Burth, Mona Ohmann, Dorothea Kronsteiner, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2018
Nonmeasurable Speckled Contrast-Enhancing Lesions Appearing During Course of Disease Are Associated With IDH Mutation in High-Grade Astrocytoma PatientsAnne Berberich, Thomas Hielscher, Philipp Kickingereder, et al.
Developmental Cell|September 5, 2017
YAP/TAZ Orchestrate VEGF Signaling during Developmental AngiogenesisXiaohong Wang, Aida Freire Valls, Géza Schermann, et al.
Neuro-Oncology Advances|July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastasesAnna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
The Lancet. Digital Health|February 26, 2022
Advancing digital health applications: priorities for innovation in real-world evidence generationAriel D Stern, Jan Brönneke, Jörg F Debatin, et al.
Pageof 2